![AUROBAC THERAPEUTICS AUROBAC THERAPEUTICS](/sites/default/files/2024-06/Boehringer_Workplace_Lab_Discussion-01_CMYK_003.png)
June 03, 2024
AUROBAC THERAPEUTICS presents strategy and growing pipeline to tackle severe infections and antimicrobial resistance
![Imagine - our new sustainability story hub A boy, his dog and his mother enjoying a day in beautiful nature](/sites/default/files/2024-05/Imagine%20-%20sustainability%20story%20hub%20-%20thumbnail_link_0.png)
May 16, 2024
Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’
![Boehringer and Click Therapeutics](/sites/default/files/2024-01/BI_Workplace_Campus_ConversationOutdoors-01_RGB_010.jpg)
January 04, 2024
FDA grants breakthrough status to schizophrenia treatment
![DINAMO_No text.png](/sites/default/files/2023-12/DINAMO_No%20text.png)
December 11, 2023
EU approves Jardiance® for treatment of type 2 diabetes in children aged 10 years and above
![R and D.png](/sites/default/files/2023-12/R%20and%20D.png)
December 07, 2023
Boehringer Ingelheim Venture Fund invests in the development of precision antimicrobials
November 15, 2023
Update on Israel and the Palestine Territories
![Drone delivery.png](/sites/default/files/2023-10/Drone%20delivery_0.png)
October 16, 2023
Addressing healthcare disparities through collaborative innovation and drone delivery
![London TSD_BI.COM TEASER IMAGE_1440x810.jpg](/sites/default/files/2023-09/London%20TSD_BI.COM%20TEASER%20IMAGE_1440x810.jpg)
September 27, 2023
World-renowned top scientists and companies take the stage at Boehringer Ingelheim’s second Transforming Science Day
![CKD FDA Approval SEO Image 1440x810.jpg](/sites/default/files/2023-09/CKD%20FDA%20Approval%20SEO%20Image%201440x810.jpg)
September 21, 2023